Literature DB >> 33025798

Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center.

Kuganathan Ramasamy1, Jeyasakthy Saniasiaya1, Norhaslinda Abdul Gani1.   

Abstract

OBJECTIVE: To investigate the prevalence of olfactory and gustatory dysfunction among patients with COVID-19 infection and the recovery rate.
METHODS: Adult patients (≥18 years) tested positive for COVID-19 via reverse transcription-polymerase chain reaction (RT-PCR) and admitted in Hospital Tuanku Ja'afar Seremban, Malaysia, were recruited in this study. Patients completed a questionnaire via telephone interview comprising the following details: age, sex, ethnicity, comorbidities, general and otorhinolaryngological symptoms, onset and duration of olfactory and gustatory dysfunction. Patients with persistent olfactory and gustatory dysfunction at the time of the initial interview were followed-up every 3 to 5 days till resolution.
RESULTS: A total of 145 patients were included in our study. The mean age of patients was 43.0 ± 17.7 (range: 18-86). Fever (44.1%) and cough (39.3%) were the most prevalent general symptoms. Thirty-one patients (21.4%) reported olfactory dysfunction and 34 (23.4%) reported dysgeusia. There was a significant association between both olfactory and gustatory dysfunction (P < .001). Altered sense of smell or taste occurred before other symptoms in 7 (15.9%); concomitant in 16 (36.4%) and after in 15 (34.1%). Six patients (13.6%) reported isolated sudden-onset anosmia. The median duration of olfactory and gustatory dysfunctions was 7 days. Complete recovery was achieved for 70.5% of the patients within 7 days of symptom onset. Only 6 (19.4%) of the 31 patients with olfactory dysfunction experienced nasal obstruction or rhinorrhea. Olfactory dysfunction was not significantly associated with nasal obstruction or rhinorrhea. Olfactory dysfunction was significantly associated with younger age (P = .002), female (P = .011), and hyperlipidemia (P = .012). Gustatory dysfunction was significantly associated with fever (P = .019) and cough (P = .039).
CONCLUSION: Olfactory and gustatory dysfunction is a pertinent manifestation of COVID-19. Most of the affected patients achieve rapid and complete recovery. Sudden onset of olfactory and gustatory dysfunction should be recognized as a major symptom of COVID-19 as we implore to contain this pandemic.

Entities:  

Keywords:  COVID-19; anosmia; coronavirus; dysgeusia; gustatory dysfunction; olfactory dysfunction

Mesh:

Year:  2020        PMID: 33025798     DOI: 10.1177/0003489420963165

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  10 in total

1.  Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

Review 2.  The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus.

Authors:  Sareesh Naduvil Narayanan; Pooja Shivappa; Sreeshma Padiyath; Anand Bhaskar; Yan Wa Li; Tarig Hakim Merghani
Journal:  Front Public Health       Date:  2022-06-06

Review 3.  Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review.

Authors:  A Boscutti; G Delvecchio; A Pigoni; G Cereda; V Ciappolino; M Bellani; P Fusar-Poli; P Brambilla
Journal:  Brain Behav Immun Health       Date:  2021-05-18

4.  Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.

Authors:  Endang Mutiawati; Marhami Fahriani; Sukamto S Mamada; Jonny Karunia Fajar; Andri Frediansyah; Helnida Anggun Maliga; Muhammad Ilmawan; Talha Bin Emran; Youdiil Ophinni; Ichsan Ichsan; Nasrul Musadir; Ali A Rabaan; Kuldeep Dhama; Syahrul Syahrul; Firzan Nainu; Harapan Harapan
Journal:  F1000Res       Date:  2021-01-21

5.  Self-reported symptom study of COVID-19 chemosensory dysfunction in Malaysia.

Authors:  Shen-Han Lee; Zhi Xiang Yeoh; Ida Sadja'ah Sachlin; Norzi Gazali; Shahrul Aiman Soelar; Chee Yoong Foo; Lee Lee Low; Sharifah Baizura Syed Alwi; Tengku Mohamed Izam Tengku Kamalden; Jothi Shanmuganathan; Masliza Zaid; Chun Yiing Wong; Hock Hin Chua; Suhaimi Yusuf; Dzawani Muhamad; Philip Rajan Devesahayam; Hong Bee Ker; Zulkiflee Salahuddin; Mahiran Mustafa; Halimuddin Sawali; Heng Gee Lee; Sobani Din; Nor Arisah Misnan; Amran Mohamad; Mohd Noor Ismail; Chenthilnathan Periasamy; Ting Soo Chow; Elang Kumaran Krishnan; Chee Loon Leong; Linda Pei Fang Lim; Nor Zaila Zaidan; Mohd Zambri Ibrahim; Suhaila Abd Wahab; Siti Sabzah Mohd Hashim
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

Review 6.  Neurological sequelae of COVID-19: a review.

Authors:  Christopher J Peterson; Ashish Sarangi; Fariha Bangash
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-09-08

7.  Recovery of olfactory and gustatory dysfunctions in coronavirus disease 2019 patients: a prospective cohort study.

Authors:  M H Taziki Balajelini; M A Vakili; A Rajabi; M Mohammadi; A Tabarraei; S M Hosseini
Journal:  J Laryngol Otol       Date:  2022-02-09       Impact factor: 1.469

Review 8.  Pathogenesis of Olfactory Disorders in COVID-19.

Authors:  Laura Ziuzia-Januszewska; Marcin Januszewski
Journal:  Brain Sci       Date:  2022-03-27

9.  Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.

Authors:  Julien Mercier; Molka Osman; Kevin Bouiller; Can Tipirdamaz; Vincent Gendrin; Catherine Chirouze; Quentin Lepiller; Elodie Bouvier; Pierre-Yves Royer; Alix Pierron; Lynda Toko; Julie Plantin; N'dri-Juliette Kadiane-Oussou; Souheil Zayet; Timothée Klopfenstein
Journal:  J Med Virol       Date:  2022-06-14       Impact factor: 20.693

Review 10.  Extrapulmonary onset manifestations of COVID-19.

Authors:  Josef Finsterer; Fulvio A Scorza; Carla A Scorza; Ana C Fiorini
Journal:  Clinics (Sao Paulo)       Date:  2021-07-05       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.